BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
PRESS RELEASE New data presented at ASCO underscores importance of Read More
PRESS RELEASE New data presented at ASCO underscores importance of Read More
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 31 Read More
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 21 Read More
PRESS RELEASE ER+ breast cancer patients reclassified as ER+ Read More
PRESS RELEASE Simultaneous creation of Global Lab Center of Excellence Read More
PRESS RELEASE Determination finds that Agendia’s MammaPrint® Breast Cancer Risk Read More
PRESS RELEASE New Studies Show MammaPrint® and BluePrint® Tests Provide Read More
PRESS RELEASE Agendia Announces New Research Reinforcing MammaPrint® and BluePrint® Read More
PRESS RELEASE Oncology Consultants Join Agendia’s FLEX Big DataRegistry Study, Read More
PRESS RELEASE Latest Results from the I-SPY 2 Trial at Read More